Skip to content
Review

Long-term cardiovascular morbidity and mortality in Turner syndrome patients with congenital heart disease: a single-center retrospective cohort study.

Oct 2026 · International Journal of Cardiology · pp. 134964 · 0 citations · 20 references
Medicine

TL;DR

Despite generally favorable functional status among survivors, progressive valve dysfunction, aortic complications and cardiovascular mortality support lifelong structured surveillance.

Abstract

Objective

Congenital cardiac anomalies are a major determinant of morbidity and mortality in Turner syndrome (TS), yet long-term cardiovascular outcome data remain limited. This study assessed cardiovascular morbidity, mortality, valve dysfunction, and aortic outcomes in TS patients with congenital cardiovascular defects.

Methods

In this single-center retrospective cohort study, 84 TS patients with congenital cardiovascular anomalies were analyzed, with follow-up between 01/1980 and 01/2025. Clinical, demographic, electrocardiographic and echocardiographic variables were reviewed; morbidity and mortality were recorded; descriptive statistics applied.

Results

Bicuspid aortic valve (BAV) was present in 40 patients (48%) and coarctation of the aorta (CoA) in 29 (35%); 19 patients (23%) had both. At last follow-up (median age 26 years, IQR 31 years), most patients were in NYHA class I (82%) and mean systolic and diastolic blood pressure were 121.7 ± 16.8 mmHg and 76.1 ± 13.1 mmHg, respectively. Sinus rhythm was present in 96% of the patients. In the BAV cohort, aortic regurgitation increased from 6 patients (15%) at first registration to 17 (42.5%) at last follow-up. In the tricuspid aortic valve cohort, aortic regurgitation increased from 1 patient (2.3%) to 12 (27.9%). The last mean ascending aortic diameter indexed to body surface area was 20.4 ± 4.6 mm/m2. Aortic dissection occurred in 2 patients (2.7%). Ten patients died during follow-up; median age at death was 41 years (IQR: 52 years), and cardiac causes accounted for at least 50% of mortality.

Conclusion

BAV and CoA predominated in this TS cohort. Despite generally favorable functional status among survivors, progressive valve dysfunction, aortic complications and cardiovascular mortality support lifelong structured surveillance.

View source

Similar papers

Open access 2026

Mortality and associated risk factors in neonates with critical congenital heart disease: A retrospective single-center study

Objective: Congenital heart diseases (CHDs) include congenital structural and functional abnormalities of the cardiovascular system and are associated with a high risk of mortality and morbidity. To evaluate early outcomes in infants with congenital heart disease (CHD), with a particular focus on critical CHD (CCHD), a...

M. Kasap Cuceoglu, Özge Altun Köroğlu, F. Ergin et al. · 0 citations
Open access Oct 2026

Long - term outcomes after the fontan surgery in patients with congenital heart disease and single - ventricle physiology at the Cardiovascular Center of E Hospital

The Fontan procedure provides favorable long - term outcomes; however, late complications remain significant; however, Lifelong surveillance is essential for optimal management.

Dac Dai Tran, Thi Thu Phuong Nghiem, Thi Hoai Thu Doan et al. · 0 citations
Review Sep 2026

Congenital Heart Defects in Kabuki Syndrome: Perioperative and Long-Term Outcomes from a 25-Year Single-Center Experience.

PurposeTo characterize the clinical characteristics, surgical experience, and long-term outcomes of patients with Kabuki syndrome (KS) and congenital heart disease (CHD).MethodsWe performed a retrospective single-center review of 37 pediatric patients with KS evaluated between January 2000 and January 2025. Among these...

M. Camacho, C. Yerebakan, Patrick McConnell et al. · 0 citations
Open access Oct 2026

Clinical Heterogeneity in Coarctation of the Aorta: Data-Driven Morbidity Sub-Phenotypes from a Nationwide Registry

Background/Objectives: Coarctation of the aorta (CoA) is associated with lifelong risks of residual or recurrent arch obstruction, hypertension, ventricular remodeling, and aortic-valve disease. We characterized documented morbidity and procedure-entry burden in a nationwide CoA registry cohort and assessed recurring m...

Paul C. Helm, Antonia Schulz, C. Niessner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.